dMed Biopharmaceutical Co Ltd

Caidya is a global clinical research organization (CRO) headquartered in New York City, New York. The company employs 137 individuals and has generated $202.5 million in revenue. Caidya specializes in advancing healthcare innovation and accelerating the development of new therapies. Caidya offers comprehensive clinical trial services encompassing a wide range of stages. Their services include regulatory strategy and submissions, clinical operations, biometrics, quality management, and post-approval surveillance. This comprehensive approach allows them to partner with clients throughout the entire drug development process. Caidya stands out through its global network spanning 23 countries and regions across the Americas, Europe, and the Asia-Pacific region. This extensive reach provides access to diverse patient populations, enabling more efficient and effective clinical trials. The company's commitment to data-driven decision-making and adherence to high-quality standards ensures reliable and impactful research outcomes. For more information about Caidya's services and expertise, visit their website at dmedglobal.com.